Kera Capital Partners, Inc.
Position in NBIX — Neurocrine Biosciences Inc
CIK 2040353
SACRAMENTO, CA
Position in NBIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$229,214
-$43,224 QoQ
Shares Held
1,360
-34.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#581
of 768 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Kera Capital Partners, Inc. holds $1,161,091 across 4 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (19.7% of the industry book) .
All Filings in NBIX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $229,214 | 1,360 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $272,438 | 2,068 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $310,324 | 2,188 | Shares | Sole | 2026-02-23 | |
| 2025-09-30 | $243,278 | 1,733 | Shares | Sole | 2025-10-27 | |
| No filing history on record for this holder in this stock. | ||||||